{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:34:32Z","timestamp":1792290872839,"version":"4.4.0"},"reference-count":32,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2019,2,28]]},"DOI":"10.5582\/irdr.2018.01099","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T22:37:07Z","timestamp":1548887827000},"page":"43-47","source":"Crossref","is-referenced-by-count":9,"title":["Guillain-Barr\u00e9 syndrome in a patient of acute Hepatitis E virus infection associated with genotype 1: Case report and literature review"],"prefix":"10.5582","volume":"8","author":[{"given":"Manish Chandra","family":"Choudhary","sequence":"first","affiliation":[{"name":"Department of Virology, Institute of Liver and Biliary Sciences"},{"name":"Molecular and Cellular Medicine department, Institute of Liver and Biliary Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijeta","family":"Bajpai","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Liver and Biliary Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovkesh","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Institute of Liver and Biliary Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Liver and Biliary Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mushahwar IK. Hepatitis E virus: Molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol. 2008; 80:646-658.","DOI":"10.1002\/jmv.21116"},{"key":"2","unstructured":"2. Hepatitis E fact sheet (revised August 2004). Wkly Epidemiol Rec. 2004; 79:314-316."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Krain LJ, Nelson KE, Labrique AB. Host immune status and response to hepatitis E virus infection. Clin Microbiol Rev. 2014; 27:139-165.","DOI":"10.1128\/CMR.00062-13"},{"key":"4","unstructured":"4. Bazerbachi F, Haffar S, Garg SK, Lake JR. Extra-hepatic manifestations associated with hepatitis E virus infection: A comprehensive review of the literature. Gastroenterol Rep (Oxf). 2016; 4:1-15."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, Keane F, Ijaz S, Izopet J, Dalton HR. Hepatitis E virus and neurologic disorders. Emerg Infect Dis. 2011; 17:173-179.","DOI":"10.3201\/eid1702.100856"},{"key":"6","unstructured":"6. Kamani P, Baijal R, Amarapurkar D, Gupte P, Patel N, Kumar P, Agal S. Guillain-Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol. 2005; 24:216."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sood A, Midha V, Sood N. Guillain-Barr\u00e9 syndrome with acute hepatitis E. Am J Gastroenterol. 2000; 95:3667-3668.","DOI":"10.1016\/S0002-9270(00)02202-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bandyopadhyay D, Ganesan V, Choudhury C, Kar SS, Karmakar P, Choudhary V, Banerjee P, Bhar D, Hajra A, Layek M, Mukhopadhyay S. Two uncommon causes of Guillain-Barre syndrome: Hepatitis E and Japanese encephalitis. Case Rep Neurol Med. 2015; 2015:759495.","DOI":"10.1155\/2015\/759495"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kumar S, Stecher G, Tamura K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016; 33:1870-1874.","DOI":"10.1093\/molbev\/msw054"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med. 2012; 366:2294-2304.","DOI":"10.1056\/NEJMra1114525"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zheng X, Yu L, Xu Q, Gu S, Tang L. Guillain-Barre syndrome caused by hepatitis E infection: Case report and literature review. BMC Infect Dis. 2018; 18:50.","DOI":"10.1186\/s12879-018-2959-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Stevens O, Claeys KG, Poesen K, Saegeman V, Van Damme P. Diagnostic challenges and clinical characteristics of hepatitis E virus-associated Guillain-Barre syndrome. JAMA neurol. 2017; 74:26-33.","DOI":"10.1001\/jamaneurol.2016.3541"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ji SB, Lee SS, Jung HC, Kim HJ, Kim HJ, Kim TH, Jung WT, Lee OJ, Song DH. A Korean patient with Guillain-Barre syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy. Clin Mol Hepatol. 2016; 22:396-399.","DOI":"10.3350\/cmh.2015.0039"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fukae J, Tsugawa J, Ouma S, Umezu T, Kusunoki S, Tsuboi Y. Guillain-Barre and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: A hospital-based survey in Japan. Neurol Sci. 2016; 37:1849-1851.","DOI":"10.1007\/s10072-016-2644-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lei JH, Tian Y, Luo HY, Chen Z, Peng F. Guillain-Barre syndrome following acute co-super-infection of hepatitis E virus and cytomegalovirus in a chronic hepatitis B virus carrier. J Med Virol. 2017; 89:368-372.","DOI":"10.1002\/jmv.24620"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Higuchi MA, Fukae J, Tsugawa J, Ouma S, Takahashi K, Mishiro S, Tsuboi Y. Dysgeusia in a patient with Guillain-Barre syndrome associated with acute hepatitis E: A case report and literature review. Intern Med. 2015; 54:1543-1546.","DOI":"10.2169\/internalmedicine.54.3506"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Perrin HB, Cintas P, Abravanel F, <i>et al<\/i>. Neurologic disorders in immunocompetent patients with autochthonous Acute Hepatitis E. Emerg Infect Dis. 2015; 21:1928-1934.","DOI":"10.3201\/eid2111.141789"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Gillen AP, Dalton HR, Jacobs BC. Guillain-Barre syndrome associated with preceding hepatitis E virus infection. Neurology. 2014; 82:491-497.","DOI":"10.1212\/WNL.0000000000000111"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chen XD, Zhou YT, Zhou JJ, Wang YW, Tong DM. Guillain-Barre syndrome and encephalitis\/encephalopathy of a rare case of Northern China acute severe hepatitis E infection. Neurol Sci. 2014; 35:1461-1463.","DOI":"10.1007\/s10072-014-1731-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Scharn N, Ganzenmueller T, Wenzel JJ, Dengler R, Heim A, Wegner F. Guillain-Barre syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c. Infection. 2014; 42:171-173.","DOI":"10.1007\/s15010-013-0448-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Woolson KL, Forbes A, Vine L, <i>et al<\/i>. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther. 2014; 40:1282-1291.","DOI":"10.1111\/apt.12986"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Comont T, Bonnet D, Sigur N, Gerdelat A, Legrand-Abravanel F, Kamar N, Alric L. Acute hepatitis E infection associated with Guillain-Barr\u00e9 syndrome in an immunocompetent patient. Rev Med Interne. 2014; 35:333-336. (in French)","DOI":"10.1016\/j.revmed.2013.05.005"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Santos L, Mesquita JR, Rocha Pereira N, Lima-Alves C, Serrao R, Figueiredo P, Reis J, Simoes J, Nascimento M, Sarmento A. Acute hepatitis E complicated by Guillain-Barre syndrome in Portugal, December 2012--a case report. Euro Surveill. 2013; 18. pii: 20563.","DOI":"10.2807\/1560-7917.ES2013.18.34.20563"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sharma B, Nagpal K, Bakki Sannegowda R, Prakash S. Hepatitis E with Gullain-Barre syndrome: Still a rare association. J Neurovirol. 2013; 19:186-187.","DOI":"10.1007\/s13365-013-0156-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Geurtsvankessel CH, Islam Z, Mohammad QD, Jacobs BC, Endtz HP, Osterhaus AD. Hepatitis E and Guillain-Barre syndrome. Clin Infect Dis. 2013; 57:1369-1370.","DOI":"10.1093\/cid\/cit512"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Maurissen I, Jeurissen A, Strauven T, Sprengers D, De Schepper B. First case of anti-ganglioside GM1-positive Guillain-Barr\u00e9 syndrome due to hepatitis E virus infection. Infection. 2012; 40:323-326.","DOI":"10.1007\/s15010-011-0185-6"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Del Bello A, Arne-Bes MC, Lavayssiere L, Kamar N. Hepatitis E virus-induced severe myositis. J Hepatol. 2012; 57:1152-1153.","DOI":"10.1016\/j.jhep.2012.05.010"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Tse AC, Cheung RT, Ho SL, Chan KH. Guillain-Barre syndrome associated with acute hepatitis E infection. J Clin Neurosci. 2012; 19:607-608.","DOI":"10.1016\/j.jocn.2011.06.024"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Cronin S, McNicholas R, Kavanagh E, Reid V, O&apos;Rourke K. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir J Med Sci. 2011; 180:255-257.","DOI":"10.1007\/s11845-010-0635-7"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Loly JP, Rikir E, Seivert M, Legros E, Defrance P, Belaiche J, Moonen G, Delwaide J. Guillain-Barre syndrome following hepatitis E. World J Gastroenterol. 2009; 15:1645-1647.","DOI":"10.3748\/wjg.15.1645"},{"key":"31","unstructured":"31. Khanam RA FM, Basunia RA, Ahsan AA. Guillain-Barr\u00e9 syndrome associated with acute HEV hepatitis. Med Coll J.2008; 1:32-34."},{"key":"32","unstructured":"32. Kumar R, Bhoi S, Kumar M, Sharma B, Singh BM, Gupta BB. Guillain-Barr\u00e9 syndrome and acute hepatitis E: A rare association. JIACM. 2002; 4:389-391."}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/8\/1\/8_2018.01099\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T04:37:25Z","timestamp":1662871045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/8\/1\/8_2018.01099\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2018.01099","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,28]]}}}